News

SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy

Sustainable lateral flow test kits developed in Birmingham reduce plastic and boost self-testing through ease of use

NICE recommends appetite suppressing drug which can reduce a patient’s by more than 10%

Greater urgency for kidney cancer treatments as 40% of UK patients wait 84 days for a diagnosis

Extensive research into pharmacy responses across Europe during the pandemic yields several recommendations

Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes

Pharma giant Sanofi continues to modernise with branding which reflects its commitment to social responsibility and sustainability

UK’s health and social care secretary will declare war on cancer with a decade-long plan to combat disease misery

Significant landmark as NICE recommends AstraZeneca’s chronic kidney disease treatment Forxiga

Research collaboration between Parkinson’s UK and Domainex has potential to improve 140,000 lives

Boost for patients with life-threatening conditions who require access to medicines not yet authorised for marketing

Coalition urges reformation of EU-wide drug research and development to drive treatment optimisation

Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity

Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis

Vulnerable people at risk from COVID-19 are set to have access to game-changing Pfizer antiviral